Showing results (121-130 of 215) with videos related to
Sort By:
Pageof 22
HIV Research & Clinical Practice|November 8, 2021
Cerebral function parameters in people with HIV switching integrase inhibitors: a randomized controlled trialBorja Mora-Peris, Michael R Keegan, Sujan Dilly Penchala, et al.AIDS (London, England)|June 6, 2025
Changes in multimorbidity burden and their impact on patient and healthcare outcomes in people with HIV over a 3-5-year periodLuxsena Sukumaran, Alan Winston, Frank A Post, et al.Neuroradiology|July 10, 2012
Two patterns of cerebral metabolite abnormalities are detected on proton magnetic resonance spectroscopy in HIV-infected subjects commencing antiretroviral therapyAlan Winston, Chris Duncombe, Patrick C K Li, et al.The Journal of Antimicrobial Chemotherapy|April 6, 2017
An association between K65R and HIV-1 subtype C viruses in patients treated with multiple NRTIsErasmus Smit, Ellen White, Duncan Clark, et al.Plos One|July 19, 2012
Acute HCV/HIV coinfection is associated with cognitive dysfunction and cerebral metabolite disturbance, but not increased microglial cell activationLucy J Garvey, Nicola Pavese, Anil Ramlackhansingh, et al.Clinical and Vaccine Immunology : CVI|April 10, 2009
Pgp3 antibody enzyme-linked immunosorbent assay, a sensitive and specific assay for seroepidemiological analysis of Chlamydia trachomatis infectionGillian S Wills, Patrick J Horner, Rosy Reynolds, et al.AIDS (London, England)|November 27, 2024
Associations between multimorbidity burden and objective and patient-reported sleep outcomes among people with HIVLuxsena Sukumaran, Caroline A Sabin, Ken M Kunisaki, et al.Journal of Neurovirology|December 7, 2021
Correlation between cerebrospinal fluid and plasma neurofilament light protein in treated HIV infection: results from the COBRA studyJasmini Alagaratnam, Davide De Francesco, Henrik Zetterberg, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 12, 2010
Does choice of combination antiretroviral therapy (cART) alter changes in cerebral function testing after 48 weeks in treatment-naive, HIV-1-infected individuals commencing cART? A randomized, controlled studyAlan Winston, Chris Duncombe, Patrick C K Li, et al.AIDS Care|March 6, 2018
Anxiety and depression symptoms in young people with perinatally acquired HIV and HIV affected young people in EnglandMarthe Le Prevost, Alejandro Arenas-Pinto, Diane Melvin, et al.Pageof 22